Immunomodulatory effects of intravenous BIS-1 F(ab')2 administration in renal cell cancer patients.

Janssen, R A

Immunomodulatory effects of intravenous BIS-1 F(ab')2 administration in renal cell cancer patients. [electronic resource] - British journal of cancer Sep 1995 - 795-9 p. digital

Publication Type: Clinical Trial; Journal Article

0007-0920

10.1038/bjc.1995.414 doi


Adjuvants, Immunologic--metabolism
Antibodies, Bispecific--metabolism
Antigens, Neoplasm--pharmacology
Carcinoma, Renal Cell--immunology
Cell Adhesion Molecules--pharmacology
Epithelial Cell Adhesion Molecule
Humans
Immunoglobulin Fragments--metabolism
Immunotherapy, Active
Injections, Intravenous
Interleukin-2--therapeutic use
Kidney Neoplasms--immunology
Leukopenia--chemically induced
Lymphocyte Activation--drug effects
T-Lymphocytes--immunology
Tumor Necrosis Factor-alpha--metabolism